InSightec's tumor ablation device wins approval in China

08/1/2013 | (Boston)

InSightec has received the go-ahead in China to market its ExAblate system for use in treating patients with uterine fibroids. The device, which uses MRI-guided focused ultrasound to allow for incision-free tumor ablation, already has been approved in the U.S. for treating patients with bone tumors.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID